Regulations.gov document
Labeling for Human Prescription Drug and Biological Products - Implementing the New Conte…
Other · FDA-2005-D-0153 · posted Jan 24, 2006
Key facts
| Document ID | FDA-2005-D-0153-0002 |
|---|---|
| Title | Labeling for Human Prescription Drug and Biological Products - Implementing the New Conte - Draft Guidance |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2005-D-0153 |
| Posted | Jan 24, 2006 |
| Comment period opens | Jan 24, 2006 |
| Comments due | Apr 25, 2006 |
At a glance
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: